Related Experiment Video

Updated: Jun 26, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

[Are the guidelines correct? Should all patients with coronary heart disease or diabetes be treated with a statin?]

Janine Pöss1, Michael Böhm, Ulrich Laufs

  • 1Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany. Janine.poess@gmx.de

Medizinische Klinik (Munich, Germany : 1983)
|January 15, 2009
PubMed

Insights

Statin drugs benefit patients by preventing coronary artery disease progression. However, elderly patients with heart failure or end-stage renal disease do not show mortality benefits from new statin therapy.

Area of Science:

  • Cardiology
  • Nephrology
  • Endocrinology

Context:

  • Current guidelines recommend statin therapy for type 2 diabetes and coronary artery disease post-myocardial infarction.
  • Recent trials (4D, CORONA, GISSI-HF) investigated statin efficacy in specific patient groups.

Purpose:

  • To evaluate the effectiveness of statin therapy in elderly patients with ischemic heart failure and in patients with diabetes and end-stage renal disease on hemodialysis.
  • To determine the primary mechanism of survival benefit from statin therapy.

Summary:

  • Statin therapy's survival benefit is mainly linked to preventing coronary artery disease progression.
  • In conditions where coronary artery disease is not the primary cause of death, statins show reduced effectiveness.
  • For patients at risk of organ damage, early statin initiation is crucial.

Impact:

  • Statin therapy may not benefit all patients, particularly the elderly with ischemic heart failure or those with advanced renal disease on dialysis, regarding mortality.
  • Discontinuation of statins in these populations is not recommended due to unknown and potentially harmful effects.
  • Evidence suggests statins are most effective when initiated early to prevent organ damage and disease progression.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...